Bioactivity | BMS-929075 is a potent and orally active HCV NS5B replicase palm site allosteric inhibitor. BMS-929075 shows high oral bioavailability. BMS-929075 shows cytotoxicity[1]. |
Invitro | BMS-929075 (0-60 µM) 显示细胞毒性,对于 Huh-7、HepG2、原代人肝细胞的CC50 值分别为 60、>12.5、>50 µM[1]。 |
In Vivo | BMS-929075 (compound 37) (静脉注射 2 mg/kg;口服 6 mg/kg) 显示出良好的药代动力学参数,大鼠口服生物利用度为 48%[1]。 |
Name | BMS-929075 |
CAS | 1217338-97-0 |
Formula | C31H24F2N4O3 |
Molar Mass | 538.54 |
Transport | Room temperature in continental US; may vary elsewhere. |
Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
Reference | [1]. Yeung KS, et al. Discovery of a Hepatitis C Virus NS5B Replicase Palm Site Allosteric Inhibitor (BMS-929075) Advanced to Phase 1 Clinical Studies. J Med Chem. 2017 May 25;60(10):4369-4385. |